Haemonetics (HAE) Accumulated Expenses (2016 - 2025)
Haemonetics has reported Accumulated Expenses over the past 16 years, most recently at $52.1 million for Q4 2025.
- For Q4 2025, Accumulated Expenses rose 13.42% year-over-year to $52.1 million; the TTM value through Dec 2025 reached $52.1 million, up 13.42%, while the annual FY2025 figure was $59.4 million, 26.37% down from the prior year.
- Accumulated Expenses for Q4 2025 was $52.1 million at Haemonetics, up from $48.3 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $80.7 million in Q1 2024 and troughed at $30.4 million in Q3 2022.
- A 5-year average of $47.6 million and a median of $46.8 million in 2021 define the central range for Accumulated Expenses.
- Biggest five-year swings in Accumulated Expenses: soared 40.52% in 2021 and later fell 26.37% in 2025.
- Year by year, Accumulated Expenses stood at $41.1 million in 2021, then increased by 27.07% to $52.2 million in 2022, then grew by 12.61% to $58.8 million in 2023, then dropped by 21.83% to $45.9 million in 2024, then increased by 13.42% to $52.1 million in 2025.
- Business Quant data shows Accumulated Expenses for HAE at $52.1 million in Q4 2025, $48.3 million in Q3 2025, and $35.8 million in Q2 2025.